[1]   Dheeraj B, Kumud U, Rishendra, K, Ravindra, PS. A recent review on tuberculosis and its treatment. Int. J. Res. Pharm. Chem., 2019; 9: 200-210.
[2]Â Â Â Varun B, Divya G, Vikrant A, Saurabh PS. Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics.RSC adv. 2015;20: 15233-15266.
[3]   Alqahtani YS, Avunoori S, Kanimehalli VM, Shaikh IA, Prem Kumar SR, Kulkarni, VH, Mannasaheb BA, Joshi, SD. Synthesis, docking studies and biological evaluation of some new pyrrolyl benzohydrazide derivatives. Ind. J. Hetero. Chem. 2024; 34: 35-42.
[4]   Mahnashi MH, Kittur B, Prem Kumar SR, Alqahtani A, Ali AA, Alshahrani AA, Shaikh IA, Joshi SD. In silico and in vitro evaluation of a new pyrrolyl benzohydrazide derivatives as potential antimicrobial agents. Ind. J. Hetero. Chem. 2022; 32: 523-530.
[5]   Avunoori S, Mahnashi MH, Momenah AM, Shaikh IA, Kulkarni VH, Joshi SD. Synthesis, docking studies and biological evaluation of some new 4-(1H-pyrrol-1-yl)benzohydrazide schiff bases. Ind. J. Hetero. Chem. 2023; 33: 233-239.
[6]   Guilherme FDSF, Herida RNS, Jean LDS. Isoniazid: A review of characteristics, properties and analytical methods. Crit Rev Anal Chem. 2017; 47 (4): 298-308.
[7]   Lourenco MCS, deSouza MVN, Pinheiro AC, Ferreira DM, Goncalves BR, Nogneira TCM. Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues, ARKIVOCxv. 2007;181-191.
[8]   Goto SK. Jo KT, Kawakita TS, Mitsuhashi ST, Nishino TN, Ohsawa N, Tanami H. Method of minimum inhibitory concentration (MIC) determination. Chemotherapy. 1981; 29: 76-79.